Platform
Features
1 follower
Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för ett flertal olika cancersjukdomar.
Industries
Headquarters
Employees
Links
Göran Forsberg
9 members
5 members
8 members
4 members
2 members
This company has no offices yet
Vaxcyte
2 followers
Arcellx
Thermo Fisher Scientific
173 followers
Gilead Sciences
133 followers
Biogen
119 followers
Alexion Pharmaceuticals
34 followers
10X Genomics
13 followers
QIAGEN
11 followers
Amyris
9 followers
Sarepta Therapeutics
PerkinElmer
Explore companies